In a meta-analysis of GLP-1RA use in T1D, all adverse events were significantly higher in the GLP-1RA group, but there was no difference in serious adverse events ( 4.5 Pediatrics Only few small studies have assessed the use of GLP-1RA as adjuvant therapy in pediatric patients with T1D
Scott Butsch, who is director of obesity medicine at the Cleveland Clinic in Ohio, who was not involved in the research
5 At one time, it was theorized that there was a single hormone responsible for this activity, but it was discovered that two hormones secreted from the intestines are primarily responsible for the incretin effect, GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
The specific time of day can vary week to week if needed, though maintaining a routine improves adherence
Cultural narratives about willpower, personal responsibility, and moral failure in obesity create receptivity to messages that frame medication as cheating, addiction, or dangerous shortcuts
Hang in there